Common Contracts

AGREEMENT AND PLAN OF MERGER dated as of June 6, 2008 among INNOVIVE PHARMACEUTICALS, INC., CYTRX CORPORATION, CYTRX MERGER SUBSIDIARY, INC. and STEVEN KELLY (As the Stockholder Representative)

Agreement and Plan of Merger • June 9th, 2008 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  June 9th, 2008
• Company
  Cytrx Corp
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

AGREEMENT AND PLAN OF MERGER (this “Agreement”) entered into on June 6, 2008, by and among INNOVIVE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), CYTRX CORPORATION, a Delaware corporation (“CytRx”), CYTRX MERGER SUBSIDIARY, INC., a Delaware corporation (“Merger Subsidiary”), and STEVEN KELLY, as the Stockholder Representative (as defined in Section 9.05).

AGREEMENT AND PLAN OF MERGER dated as of June 6, 2008 among INNOVIVE PHARMACEUTICALS, INC., CYTRX CORPORATION, CYTRX MERGER SUBSIDIARY, INC. and STEVEN KELLY (As the Stockholder Representative)

Agreement and Plan of Merger • June 9th, 2008 • Innovive Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  June 9th, 2008
• Company
  Innovive Pharmaceuticals, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

AGREEMENT AND PLAN OF MERGER (this “Agreement”) entered into on June 6, 2008, by and among INNOVIVE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), CYTRX CORPORATION, a Delaware corporation (“CytRx”), CYTRX MERGER SUBSIDIARY, INC., a Delaware corporation (“Merger Subsidiary”), and STEVEN KELLY, as the Stockholder Representative (as defined in Section 9.05).